Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CABG: lessons from the randomized trials.

G C Kaiser

    The Annals of Thoracic Surgery
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Coronary artery bypass grafting (CABG) increases survival for patients with severe ischemic heart disease, reducing fatal heart attacks. Treatment outcomes are similar across age groups but influenced by other health conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.

    Journal of pediatric gastroenterology and nutrition·2005
    Same author

    Accountability: the future application of cardiothoracic surgical data in a changing health care environment.

    The Annals of thoracic surgery·1999
    Same author

    Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase.

    Experimental cell research·1999
    Same author

    Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes.

    Gastroenterology·1999
    Same author

    CASS Registry long term surgical survival. Coronary Artery Surgery Study.

    Journal of the American College of Cardiology·1999
    Same author

    Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses.

    The Annals of thoracic surgery·1998
    Same journal

    Late outcomes of postoperative complete heart block after congenital heart surgery: recovery or re-heart block?

    The Annals of thoracic surgery·2026
    Same journal

    Coronary artery bypass grafting based on computed tomography-derived fractional flow reserve versus angiography: Early results.

    The Annals of thoracic surgery·2026
    Same journal

    Beyond R0: Margin Cytology and Local Control After Sublobar Resection.

    The Annals of thoracic surgery·2026
    Same journal

    Deferred AVR During CABG in Moderate Aortic Stenosis: Lower Index Risk or Deferred Cumulative Risk?

    The Annals of thoracic surgery·2026
    Same journal

    The Renaissance of Transapical TAVR: From Competing Access Route to Enabling Platform for Hybrid Heart Therapy.

    The Annals of thoracic surgery·2026
    Same journal

    A Moving Target: Interpreting Post-TAVI Reintervention in a Rapidly Evolving Era.

    The Annals of thoracic surgery·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Cardiac Surgery
    • Clinical Trials

    Background:

    • Ischemic heart disease poses significant survival challenges.
    • Medical and surgical interventions are key management strategies.
    • Large-scale trials are crucial for evaluating treatment efficacy.

    Purpose of the Study:

    • To evaluate the long-term effects of medical versus surgical management for ischemic heart disease.
    • To assess the impact of coronary artery bypass grafting (CABG) on survival and secondary endpoints.
    • To analyze treatment outcomes in specific patient subgroups, including those with left ventricular dysfunction and the elderly.

    Main Methods:

    • Analysis of data from three large cooperative randomized trials.
    • Comparison of survival rates and secondary endpoints between medical management and CABG.

    Related Experiment Videos

  • Stratification of results based on disease severity (e.g., left main stenosis, triple-vessel disease) and left ventricular function.

    • Main Results:

    • CABG significantly increases survival in patients with left main coronary artery stenosis, triple-vessel disease, double-vessel disease, left ventricular functional impairment, or left ventricular aneurysm.
    • CABG reduces the incidence of fatal myocardial infarction but not nonfatal events.
    • Outcomes in patients aged 65 and older are comparable to younger patients, though influenced by comorbidities.
    • Gainful employment and risk factors remain unaffected by treatment.
    • CABG alone did not improve congestive heart failure symptoms; LV aneurysmectomy did.

    Conclusions:

    • CABG offers survival benefits for specific patient populations with ischemic heart disease.
    • The procedure effectively reduces fatal myocardial infarction incidence.
    • Surgical intervention, particularly LV aneurysmectomy, can address specific complications like heart failure symptoms.